NVP-2, in combination with Orlistat, represents a promising therapeutic strategy for acute myeloid leukemia.
Zhu Q, Cheng J, Gao Y, Zhang Z, Pan J, Su X, Fei D, Cai L, Yu J, Chen Y, Jiao W, Wu D, Li X, Xiao P.
Zhu Q, et al. Among authors: wu d.
Cancer Biol Ther. 2025 Dec;26(1):2450859. doi: 10.1080/15384047.2025.2450859. Epub 2025 Jan 12.
Cancer Biol Ther. 2025.
PMID: 39800696